Strategic and tactical insights on pharmaceutical market access topics spanning distribution, pharmacy, and access and affordability.
Categories
2025 Market Access Forecast: Four Game-Changing Trends Reshaping Pharma
Four Pivotal Trends Revolutionizing Market Access Strategies
Fair Market Value vs. Current Market Leverage
How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services
Archbow Consulting Strengthens Leadership Team with Key Promotions
Strategic appointments reflect Archbow’s continued growth and commitment to delivering exceptional value to its clients.
Archbow Consulting: A Committed Partner to NASP
As the only national nonprofit organization representing all specialty pharmacy stakeholders, NASP plays a crucial role in advancing the specialty pharmacy field.
ECRM 2025: Key Trends & Opportunities
Uncovering insights in the pharmaceutical industry, including optimizing supply chain solutions and refining market access strategies.
Navigating the Evolving Pharma Landscape: A Year in Review
As 2024 draws to a close, Archbow Consulting reflects on a year of dynamic change within the pharmaceutical industry.
Revolutionizing Patient Care: The Top 5 Benefits of Investing in Innovation
Why manufacturers must embrace innovative trends to stay ahead
FDA Extends Compliance Deadline for Updated DSCSA Requirements
Understanding the revised timeline for compliance with specific updated DSCSA requirements
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|